Dr. Goldman joined WCAS in 2017 as an Operating Partner and
focuses on healthcare investments. He has worked with WCAS
previously, serving as the Chief Executive Officer of Aptuit, a
former WCAS portfolio company. Dr. Goldman brings 28 years of
experience in healthcare, having held senior executive positions in
sales, operations and medical oversight at ICON Plc, a leading
global contract research organization, as well as Point Biomedical,
a development-stage biopharmaceutical company responsible for
discovering and developing microsphere-based pharmaceuticals.
He currently maintains a Faculty appointment as an Associate
Clinical Professor of Medicine in the division of Cardiology at the
University of California, San Francisco.
He has BSc, MBBS and MD degrees from the University of London,
in addition to Executive MBA qualifications from Columbia
University in New York, and the University of California at
Berkeley. He trained in internal medicine and cardiology in
leading UK and US institutions; his academic accomplishments
include authorship of over 100 scientific publications and
Fellowship of prominent medical societies, including the American
College of Cardiology, the American Heart Association, and the
Royal College of Physicians in the UK.